University of Michigan — Innovation Partnerships (Accelerate Blue Fund)
University of Michigan's Innovation Partnerships Ventures team manages the Accelerate Blue Fund, an evergreen early-stage venture fund that exclusively invests in startups licensed from University of Michigan research. It also launched the Michigan University Innovation Capital Fund in 2024 to support pre-seed startups across Michigan's public universities.
Deal activity decreased year-over-year (2 deals in the last 12 months vs 3 prior). Average disclosed round size is $33.1M (across 13 rounds with reported amounts).
Portfolio
16
Fund Size
$15.6M
Top Stage
Seed
Last 12 Mo
2
Team
Dave Repp
Director of Ventures and Managing Director of the Accelerate Blue Fund
Amanda Sorensen
Director of Operations
Anthony Licavoli
Associate Director of Compliance and Patent Administration
Ashwathi Iyer
Director of Software and Content Licensing and Research Partnerships
Denise Graves
Commercialization Program Director, MTRAC Transportation
Don Manfredi
Associate Director of Ventures and Fund Manager
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Sygaldry | Series A | $105M | Apr 2026 |
 Skeletalis | Seed | $8M | Nov 2025 |
| CCourage Therapeutics | Seed | $7.8M | May 2025 |
 Rescale | Series D | — | Apr 2025 |
 X-energy | Series C | — | Oct 2024 |
 Geminus | Seed | $5.9M | Jan 2024 |
 STOKE Space | Series B | $100M | Oct 2023 |
| STOKE Space | Growth | $100M | Dec 2021 |
 Akadeum | Series B | $17.5M | Oct 2021 |
| BBlueWillow Biologics | Series A | $10M | May 2018 |
| VViewPoint Therapeutics | Series B | $35M | Mar 2018 |
 Ecovia Renewables | Seed | $1M | Jan 2015 |
 Crossbar | Unknown | — | — |
| X-energy | Series C | — | — |
 Confo Therapeutics | Series A | — | — |
| CCROSSBAR, INC. | Series D | $35M | — |
 GripFusion | Seed | $4M | — |
 Fibarcode | Pre-Seed | $500K | — |
Top Co-Investors
Last updated: 8 September 2026